Tag Archives: Opsumit

IPO Alert: Actelion founders launch startup on $1.5 billion J&J payday: call your broker, soon

Steve’s Take: If ever there was a “story” biotech IPO worth grabbing even a tiny piece of, this is it. First, the story: Two decades ago Jean-Paul and Martine Clozel… Read more »

J&J finally captures Actelion for $30 billion; deal looks good for both unless “what ifs” bite pharma giant’s shareholders

The News: It took months but Swiss biotech Actelion Ltd. (Allschwil) said on Thursday (January 26, 2017) it had agreed to be purchased by Johnson & Johnson (New Brunswick NJ) in a… Read more »

Johnson & Johnson eyeing Actelion; who wouldn’t with a “pro-biotech” Trump administration?

Johnson & Johnson (New Brunswick NJ) said Friday (November 11, 2016) it is in “preliminary discussions” with Swiss drug company Actelion Pharmaceuticals Ltd. (Basel CHE), a deal that would help the… Read more »